Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Development and Evaluation of a Standardized Rat Model for Calvarial Suture-Bony Composite Defects
Published on: May 10, 2024
Stem Cell Membrane-Coated Microribbon Scaffolds Induce Regenerative Innate and Adaptive Immune Responses in a
Ni Su1, Cassandra Villicana2, Danial Barati1
1Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Mesenchymal stem cell membrane-coated scaffolds show promise for healing critical-sized bone defects by modulating immune responses. This approach enhances bone regeneration and reduces inflammation, offering a new strategy for tissue repair.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Immunology
Background:
- Cell membranes functionalize nanoparticles for drug delivery, but their use in tissue scaffolds for in vivo regeneration is unexplored.
- Scaffold immunomodulation is key for tissue regeneration, yet limited to soft tissues.
- Critical-sized bone defects require novel healing strategies, with adaptive immune cell roles unclear.
Purpose of the Study:
- To investigate mesenchymal stem cell membrane (MSCM)-coated microribbon (µRB) scaffolds for treating critical-sized cranial bone defects.
- To explore the immunomodulatory potential of MSCM-coated scaffolds in bone regeneration.
- To assess the effect of MSCM coating on immune cell behavior and bone healing in vivo.
Main Methods:
- Fabrication of microribbon (µRB) scaffolds coated with mesenchymal stem cell membranes (MSCM).
- Confocal imaging and proteomic analysis to confirm coating and characterize composition.
- In vitro and in vivo studies to evaluate macrophage polarization, T cell responses, and bone regeneration.
Main Results:
- Successful coating of µRB scaffolds with MSCM confirmed.
- MSCM coating promoted macrophage polarization to a regenerative phenotype.
- MSCM coating induced CD8+ T cell apoptosis and enhanced regulatory T cell differentiation.
- Combined MSCM coating and BMP-2 accelerated bone regeneration and suppressed inflammation.
Conclusions:
- MSCM-coated microribbon scaffolds represent a promising strategy for treating critical-sized bone defects through targeted immunomodulation.
- This platform offers broad applicability for enhancing tissue regeneration across different tissue types using various cell membranes and scaffolds.
- The findings highlight the potential of cell membrane biomimicry for engineering advanced regenerative medicine therapies.
More Related Videos
11:31Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
Published on: October 31, 2012
09:35Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
Published on: September 11, 2015